Fundraising Fox

Capricorn Venture Partners

Venture capitaloperating company · company profile

Leuven · Seed–Late Stage · 30 people tracked

Find your way into Capricorn Venture Partners

1,945 people in our graph share verified history with the Capricorn Venture Partners team — schools, employers, funds. One of them is your warm intro.

Alain le Louxunlockedknows Katrin Geyskens · together at EIT Digital (overlapped)
×3knows the team · via Stanford University
knows the team · via The Boston Consulting Group
×2knows the team · via Stanford University Graduate School of Business
×4knows the team · via A.T.Kearney
knows the team · via Akzo Nobel Catalysts
Fox Verdict
Sign up to see your fit

Investment thesis

Capricorn Partners seeks both financial return and strategic value by investing in innovative companies that positively impact people and the planet. It combines technology and investment expertise, offering venture and growth capital focused on three core areas: digital technologies, health, and clean technologies. The firm monitors emerging trends to shape future investment themes while maintaining an ESG commitment. Its Quest for Growth vehicle invests in both quoted and unquoted growth companies, primarily European, building unquoted exposure through direct investments or via venture/growth capital funds, concentrating on industries and themes expected to deliver higher than average growth.

Source: firm website, verified Aug 7, 2026.

Stage
Seed–Late Stage
Check
$270K – $10.8M
HQ
Leuven, BE
Leads rounds
Leads
Instruments
Equity
Founded
1993
Last 12 months
2 investments
AUM
$330M
Tracked investments
70

Team · 30 people

from the firm's website & public directories
Katrin Geyskens· Executive Directorin

Executive director at Capricorn Partners.

Ludwig Goris· Partnerin
Simon Wouters· Investment Managerin
Anneleen Peeters· Non-executive Directorin

Non-executive director and member of the audit & risk committee.

Bart De Smet· Independent Director

Independent director and member of the remuneration & nomination committee.

Jeroen Van Iseghem· Investment Analystin
Kim De Keyser· Valuation Expertin
Maud Watelet· Independent Director

Independent director and member of the audit & risk committee.

Noé Wachsmuth· Visiting Analystin
Maarten Lambert· Senior Associate

What they invest in

from 25 of 70 portfolio companies

AI & Machine Learning ×11Deep Tech ×7Advanced Manufacturing ×6Biotech ×6SaaS ×6Cleantech ×5Medical Devices ×5New Materials ×5

HQs:Belgium×9United States×3Germany×2Netherlands×2Australia×1Norway×1

Who they back

founder profiles across 10 portfolio companies
70%
solo founders
7 of 10 mapped founding teams
30%
repeat founders
of 10 founders with career history

Founding team size:solo founder×72 founders×23 founders×1

What their founders studiedfrom 11 founders with field-of-study data

Engineering ×6

Where their founders worked beforefrom 10 founders with career history

Vrije Universiteit Brussel ×2

Investments · 70 tracked

founders shown can be your intro path

By year:2026 · 12025 · 12 dated

DMC Biotechnologiesdmcbio.comin𝕏Dec 2025SEC filingmedium confidence

DMC Biotechnologies is a U.S.-based biomanufacturer that uses precision fermentation and its Dynamic Metabolic Control platform to produce bio-based specialty chemicals and ingredients, such as L-alanine and fermented inositols.

BiotechClimate TechNew MaterialsBoulder, US

Matthew Lipscomb(Director)Josh Yelen(Executive Officer)Jim Flatt(Executive Officer, Director)in

BoardJosko Bobanovic(Director)Alastair Cooper(Director)

Board seatRob van der Meij· per SEC Form D · $2.5M raise · filed Dec 2025

Co-investorsBreakthrough Energy VenturesSofinnova PartnersBoulder Ventures

Trillium Renewable Chemicalstrilliumchemicals.cominJun 2026

Trillium Chemicals produces acrylonitrile from renewable feedstocks like glycerol as a sustainable alternative to fossil-based production.

CleantechClimate TechNew MaterialsKnoxville, US

Corey Tyree(Executive Officer, Director, Promoter)in

BoardCorinne Augelli-Szafran(Director)Ian MacDougall(Director)Erik Scher(Director)Young Joon Lee(Director)

Board seatWouter Van de PutteRob van der Meij· per SEC Form D

Aestuarium
Aspect Analyticsaspect-analytics.comin

Aspect Analytics develops computational infrastructure for spatial biology analysis, enabling scientists to extract actionable insight from multimodal biological data to accelerate drug development.

AI & Machine LearningBiotechData & InfrastructureDeep TechSaaS

Co-investorsHeran PartnersPMV

Avantiumavantium.comin𝕏

Avantium develops bio-based materials and polymer technologies, including PEF and other renewable alternatives to conventional plastics, serving the packaging and materials industry.

BiotechCircular EconomyCleantechNew MaterialsNetherlands, NL

Co-investorsNavitas CapitalAster CapitalNV NOMPMVSignet Healthcare PartnersSofinnova Partners+2 more

Azumutaazumuta.comin𝕏

Azumuta offers a cloud-based Manufacturing Execution System (MES) that manages shop floor operations including digital work instructions, quality checks, production orders, traceability, and machine and ERP integrations.

Advanced ManufacturingAI & Machine LearningEnterprise SoftwareFuture of WorkIoTSaaSGhent, BE

Batist Leman(CEO)in

Co-investorsKeen Venture PartnersAngelwisePMV

Beijer Alma
Bingli
Bluebee

Cloud-based accelerated genomics platform for genomic labs and diagnostics.

Co-investorsKorysPMV

c-LEctac-lecta.comin

c-lecta introduces its management team and staff of over 130 employees.

Advanced ManufacturingBiotechFoodTechLeipzig, DE

Capricorn Cleantech
Capricorn Fusion
Capricorn Fusion China Fund
Capricorn Health
Capricorn Healthtech Fundcapricorn.be

Capricorn Healthtech Fund is a venture capital fund managed by Capricorn Partners that invests in European digital health and medtech startups, not a startup itself.

Capricorn SCF
Cartageniaacquired by Agilent · May 2015

Cartagenia was a Leuven, Belgium-based bioinformatics company, spun out of KU Leuven, that developed the Bench Lab software platform for clinical genetics and molecular pathology labs to analyze and report genomic variant data from next-generation sequencing and microarrays.

CEWE
Chainels
Confo Therapeuticsconfotherapeutics.comin

VIB is a non-profit research institute focused on strategic basic research in life sciences, operating in partnership with five Flemish universities.

BiotechDeep TechMedical DevicesGhent, BE

Jan Steyaert(Founder (Scientific))inCedric Ververken(CEO)in

Co-investorsFund+PMVQuest for GrowthV-Bio VenturesBioGeneration Ventures

Conxai
DAB.bio
Diagenodediagenode.comin𝕏

Hologic Diagenode provides epigenomics profiling services and sample preparation products for next-generation sequencing, proteomics, and epigenetics research.

BiotechDeep TechHealthtech

DMC
EclecticIQeclecticiq.comin𝕏

EclecticIQ builds a threat intelligence platform powered by AI to help organizations address cybersecurity challenges.

AI & Machine LearningCybersecurityEnterprise SoftwareAmsterdam, NL

Cody Barrow(Chief Executive Officer)in

Co-investorsCuriosity VCKeen Venture PartnersKPN VenturesTIIN CapitalInkef

Econic
Endotoolsendotools.bein

Endo Tools Therapeutics develops endoscopic devices to enable minimally invasive therapeutic surgical procedures in gastroenterology.

HealthtechMedical DevicesGosselies, BE

Co-investorsWhite Fund

EQT Life Sciences
Equasensequasens.comin

This page is a financial analysis archive from Equasens' investor relations section, containing links to analyst reports and earnings commentary from various financial research firms.

Digital HealthEdTechHealthtech

ExCultureexculturebiotech.com

ExCulture is a Dutch biotech startup founded in 2022 in Leiden developing a fermentation-based, animal-free substitute for heparin, the widely used blood thinner traditionally derived from pig intestines.

FEopsfeops.comin

FEops develops a cloud-based procedure planning platform for interventional cardiologists that uses predictive simulation and AI-based anatomical analysis to optimize device selection and placement for structural heart interventions like LAAO and TAVI procedures.

AI & Machine LearningCloud ComputingDigital HealthMedical Devices

Matthieu De Beule(Co-founder and CEO)inPeter Mortier(Co-founder and CTO)inNico

Co-investorsPMV

Finquest
Foamlab
Fruitcorefruitcore-robotics.comin

fruitcore robotics builds industrial robots and humanoid automation systems, including its Industrial Humanoid Platform for demanding manufacturing tasks such as assembly, handling, and quality inspection.

Advanced ManufacturingAI & Machine LearningHardwareRobotics

Jens Riegger(Founder)in

Co-investorsBLN CapitalKOMPAS VCMatterwave VenturesUVC PartnersCNB Capital

Gradyentgradyent.aiin

Gradyent offers digital tools for optimizing and decarbonizing industrial steam grids, aimed at industrial operators seeking to reduce emissions.

AI & Machine LearningCleantechClimate TechEnergySaaS

Hervé Huisman(Founder)in

Icometrixicometrix.comin𝕏

Icometrix develops AI-powered medical imaging software for analyzing brain MRI scans to help clinicians diagnose and monitor neurological conditions like Alzheimer's disease, stroke, and traumatic brain injury.

AI & Machine LearningDigital HealthMedical DevicesLeuven, BE

Wim Van Hecke(Founder)in

Co-investorsForestay CapitalHeran PartnersOptum Ventures

Indigo Diabetes

Co-investorsPMV

InsectSense
Kerry Group
Kingspan
Krones
Melexis
Mensch und Machine
Minzeminzehealth.comin𝕏

Minze Health develops solutions for diagnosing and managing lower urinary tract symptoms (LUTS), such as those caused by benign prostatic hyperplasia (BPH) or overactive bladder (OAB).

Digital HealthHealthtechMedical Devices

Co-investorsPMVWhite Fund

NEFFA
Neotiv
Ng Datangdata.comin

NGDATA is a customer engagement platform company that uses artificial intelligence and data analytics to help businesses create personalized customer experiences.

AI & Machine LearningData & InfrastructureFintechMarketing TechSaaSNew York, US

Geert Crombez(Chief Technology Officer)in

Co-investorsHPE GrowthPamica NVSmartFin

Noona
Norbitnorbit.comin

NORBIT is a technology company with business units in oceans, connectivity, and product innovation, developing sonar/underwater sensing systems and electronic tolling and connectivity technologies.

Deep TechHardwareIoT

Per Jørgen Weisethaunet(CEO)inPer Kristian Reppe(CFO)inJulie Dahl Benum(Chief Strategy Officer and Acting Chief Commercial Officer PIR)inAstrid Stevik(Chief Operating Officer)inPeter K. Eriksen(Business Unit Director Oceans)inLino Morgione(Chief Commercial Officer Connectivity)in

Ogedaacquired by Astellas Pharma · Apr 2017

Ogeda was a Belgian clinical-stage biotech, spun off from Euroscreen, that developed small-molecule drugs targeting GPCRs, including the NK3 antagonist fezolinetant for menopausal hot flashes.

Co-investorsVesalius Biocapital Partners

Oska Health
Prolupinprolupin.comin𝕏

Wide Open Agriculture transforms lupins, a crop primarily grown in Western Australia, into functional protein ingredients for global food and beverage manufacturers.

AgTechFoodTechNew MaterialsPerth, AU

Co-investorsMunich Venture Partners

Punch Powertrainpunchpowertrain.comin𝕏

Punch Powertrain develops powertrain solutions for combustion, hybrid, and electric vehicles, serving the automotive industry globally.

Advanced ManufacturingCleantechMobility & Transportation

Quest for Growth
Robertet
Scaled Access
SP Group
Spectricityspectricity.comin

Spectricity develops spectral sensing solutions using CMOS technology for consumer and mobile devices.

AI & Machine LearningDeep TechHardwareSemiconductorsBelgium, BE

Glenn Vandevoorde(CEO)

BoardPieter Vorenkamp(Chairman of the Board)

Co-investorsAtlantic Bridge Venturesimec.xpand

StoryChiefstorychief.ioin

StoryChief is a content operations platform that combines strategy, creation, feedback, publishing, and performance analytics in one place for marketing teams, multi-brand organizations, and agencies.

AI & Machine LearningMarketing TechMedia & EntertainmentSaaSGhent, BE

Gregory Claeyssens(Founder)inBrik De Maeyer(Founder)in

Co-investorsPeakPMV

Thermador Groupe

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 2

IPOs and acquisitions across the tracked portfolio

Cartageniaacq. by AgilentOgedaacq. by Astellas Pharma

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Capricorn Venture Partners made?
Capricorn Venture Partners has 69 tracked investments, 2 of which have exited via acquisition or IPO, including 1 dated in the last 24 months.
What stage does Capricorn Venture Partners invest at?
Capricorn Venture Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Capricorn Venture Partners's typical check size?
Capricorn Venture Partners typically writes checks of $270K – $10.8M.
What sectors does Capricorn Venture Partners focus on?
Capricorn Venture Partners focuses on AI & Machine Learning, Biotech, Circular Economy, Cleantech, Climate Tech, Cloud Computing, Data & Infrastructure, Deep Tech, Digital Health, Healthtech, Medical Devices, Robotics.
Where is Capricorn Venture Partners located?
Capricorn Venture Partners is headquartered in Leuven, BE.
Does Capricorn Venture Partners lead rounds?
Yes, Capricorn Venture Partners leads investment rounds.
Who does Capricorn Venture Partners co-invest with?
Capricorn Venture Partners most often shares deals with PMV, Heran Partners, Keen Venture Partners, among 31 tracked co-investors.

Images

Capricorn Venture Partners photo

Similar investors

Featured in lists